Skip to main content
Have a personal or library account? Click to login
Ethical dilemmas related to the use of new reproductive genetics technologies Cover

Ethical dilemmas related to the use of new reproductive genetics technologies

By:  and    
Open Access
|May 2026

References

  1. Rehmann-Sutter C.: Should prenatal screening be seen as ‘selective reproduction’? Four reasons to reframe the ethical debate, J Perinat Med. 2021 Jul 1;49(8):953-958.
  2. Zaami S., Orrico A., Signore F., Cavaliere A.F., Mazzi M., Marinelli E.: Legal and Social Issues (ELSI) Associated with Non-Invasive Prenatal Testing: Reflections on the Evolution of Prenatal Diagnosis and Procreative Choices, Genes (Basel). 2021 Jan 30;12(2):204.
  3. Raposo V.L.: From Public Eugenics to Private Eugenics: What Does the Future Hold? JBRA Assist Reprod. 2022 Nov 9;26(4): 666-674.
  4. Gottfredsdóttir H., Björnsdóttir K.: ‘Have you had the test?’ A discourse analysis of media presentation of prenatal screening in Iceland, Scand J Caring Sci. 2010 Jun;24(2):414-21.
  5. Ahumada-Ayala M., Aguilar-Lopez R., Gonzalez-Stoylov N., Palacio-Sosa E., Cervantes-Barragan D.E., Fernandez-Hernandez L.: Editing the Human Genome with CRISPRCas A Review of its Molecular Basis, Current Clinical Applications, and Bioethical Implications, Rev Invest Clin. 2023;75(1):13-28.
  6. Fogleman S., Santana C., Bishop C., Miller A., Capco D.G.: CRISPR/Cas9 and mitochondrial gene replacement therapy: promising techniques and ethical considerations, Am J Stem Cells. 2016 Aug 20;5(2):39-52
  7. Plaza Reyes A., Lanner F.: Towards a CRISPR view of early human development: applications, limitations and ethical concerns of genome editing in human embryos, Development. 2017 Jan 1;144(1): 3-7
  8. Moreira Farnezi H.C., Xavier Goulart A.C., Dos Santos A., Gontijo Ramos M., Firpe Penna M. L.: Three-parent babies: Mitochondrial replacement therapies, JBRA Assist Reprod. 2020 May 1;24(2):189-196.
  9. Palacios-Gonzalez C.: Mitochondrial replacement techniques: egg donation, genealogy and eugenics, Monash Bioeth Rev. 2016 Mar;34(1):37-51.
  10. Tachibana M., Takashi K., Nobuo Y.: Mitochondrial replacement therapy and assisted reproductive technology: A paradigm shift toward treatment of genetic diseases in gametes or in early embryos, Reprod Med Biol 2018 Sep 19;17(4):421-433.
  11. A.S., Huyser C., Pepper M.S.: Mitochondrial transfer: Implications for assisted reproductive technologies, Appl Transl Genom. 2016 Oct 15:11:40-47.
  12. Gómez-Tatay L., Hernandez-Andreu J.M., Aznar J.: Mitochondrial Modification Techniques and Ethical Issues, J Clin Med. 2017 Feb 24;6(3):25
  13. Palacios-González C.: Does egg donation for mitochondrial replacement techniques generate parental responsibilities? J Med Ethics. 2018 Dec;44(12):817-822.
  14. Blesa J.R., Tudela J., Aznar J: Ethical aspects of nuclear and mitochondrial DNA transfer, Linacre Q. 2016 May;83(2):179-191.
  15. Coller B.S.: Ethics of Human Genome Editing, Annu Rev Med. 2019 Jan 27:70:289-305.
  16. Gabel I., Moreno J.: Genome Editing, Ethics, and Politics, AMA J Ethics. 2019 Dec 1;21(12):E1105-1110.
  17. Brokowski C., Adli M.: CRISPR ethics: moral considerations for applications of a powerful tool, J Mol Biol. 2019 Jan 4;431(1): 88 - 101
  18. Dahiya N., Garg S.: Three-parent baby: Is it ethical? Indian J Med Ethics. 2018 Apr-Jun;3(2):169
  19. Dimond R.: Social and ethical issues in mitochondrial donation, Br Med Bull. 2015 Sep;115(1):173-82.
  20. Cohen I.G., Adashi E.Y. Gerke S., Palacios-Gonzales C., Ravitsky V.: The Regulation of Mitochondrial Replacement Techniques Around the World, Annu Rev Genomics Hum Genet. 2020 Aug 31:21:565-586.
DOI: https://doi.org/10.2478/orvtudert-2025-0002 | Journal eISSN: 2537-5059 | Journal ISSN: 1453-0953
Language: English
Page range: 14 - 27
Published on: May 21, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2026 Demeter Timea, Csép Katalin, published by Transylvanian Museum Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.